MS-40

N/A

Report date: 2026/01/14 10:59:59
NME

Base Information

Drug NameMS-40
Drug Alias NameMS-40
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionZinc finger protein Aiolos degradersDNA-binding protein Ikaros inhibitorsWD repeat-containing protein 5 inhibitors
TargetsZinc finger protein AiolosWD repeat-containing protein 5DNA-binding protein Ikaros
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of North Carolina At Chapel Hill
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of North Carolina At Chapel Hill
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A